📰 Director Daniel News
Page 32 - Director Daniel News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Director Daniel. Real-time updates on events, politics, business and more.
January 23, 2024
Signaturefd LLC lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.0% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,241 shares of the healthcare product maker’s stock after selling 1,277 shares during the quarter. Signaturefd […]
January 23, 2024
Camden National Bank cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 3.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,486 shares of the healthcare product maker’s stock after selling 151 shares during the period. Camden National […]
January 22, 2024
Bahl & Gaynor Inc. lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 17.3% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,069,348 shares of the healthcare product maker’s stock after selling 433,068 shares during the period. Abbott Laboratories accounts […]
January 22, 2024
Montag & Caldwell LLC increased its position in shares of Copart, Inc. (NASDAQ:CPRT – Free Report) by 100.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,572 shares of the business services provider’s stock after purchasing an additional 11,286 shares during the […]
January 22, 2024
Advisor OS LLC raised its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 23.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,021 shares of the healthcare product maker’s stock after acquiring an additional 1,327 shares during the quarter. Advisor […]
January 22, 2024
ORG Partners LLC cut its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 3.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 36,603 shares of the healthcare product maker’s stock after selling 1,121 shares during the quarter. Abbott Laboratories […]
January 21, 2024
Fidelity National Financial, Inc. (NYSE:FNF – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven brokerages that are covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price objective among […]
January 21, 2024
Lmcg Investments LLC cut its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 129,777 shares of the healthcare product maker’s stock after selling 2,323 shares during the period. Abbott […]
January 19, 2024
Empirical Finance LLC increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 10.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 60,817 shares of the healthcare product maker’s stock after buying an additional 5,809 shares during the period. Empirical Finance […]
January 19, 2024
Gilbert & Cook Inc. reduced its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 14.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,436 shares of the healthcare product maker’s stock after selling 1,050 shares during the quarter. Gilbert […]